{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:49:32Z","timestamp":1793371772458,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008054","name":"Ramon Areces Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127626","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:56:03Z","timestamp":1756317363000},"page":"127626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Innate and T-cellular immune responses to sequential vaccination with chimeric hemagglutinin split influenza virus vaccines in mice"],"prefix":"10.1016","volume":"63","author":[{"given":"Kirill","family":"Vasilev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Puente-Massaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Hoxie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Bushfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127626_bb0005","article-title":"Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines","volume":"10","author":"Trombetta","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127626_bb0010","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2421096","article-title":"Seasonal influenza vaccines: variability of immune responses to B lineage viruses","volume":"20","author":"Miller","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127626_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13276","article-title":"Recent advances, approaches and challenges in the development of universal influenza vaccines","volume":"18","author":"Lim","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2025.127626_bb0020","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127626_bb0025","article-title":"Chimeric hemagglutinin-based live-attenuated vaccines confer durable protective immunity against influenza a viruses in a preclinical ferret model","volume":"9","author":"Liu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127626_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127626_bb0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127626_bb0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S1473-3099(22)00024-X","article-title":"Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial","volume":"22","author":"Folschweiller","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127626_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127626_bb0050","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0055","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza a viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2025.127626_bb0065","article-title":"Harnessing the power of T cells: the promising hope for a universal influenza vaccine","volume":"6","author":"Clemens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127626_bb0070","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JVI.02371-10","article-title":"Vaccination against seasonal influenza a\/H3N2 virus reduces the induction of heterosubtypic immunity against influenza a\/H5N1 virus infection in ferrets","volume":"85","author":"Bodewes","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0075","doi-asserted-by":"crossref","first-page":"11690","DOI":"10.1128\/JVI.74.24.11690-11696.2000","article-title":"Profound protection against respiratory challenge with a lethal H7N7 influenza a virus by increasing the magnitude of CD8(+) T-cell memory","volume":"74","author":"Christensen","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0080","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza a\/H3N2 virus induces protective immunity against lethal infection with influenza a\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127626_bb0085","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza a virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127626_bb0090","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1080\/21645515.2018.1502529","article-title":"Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site","volume":"14","author":"Kotomina","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127626_bb0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1586\/14760584.2014.922417","article-title":"Development of live attenuated influenza vaccines against pandemic influenza strains","volume":"13","author":"Coelingh","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127626_bb0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14760584.2018.1541407","article-title":"Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine","volume":"17","author":"Korenkov","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127626_bb0105","first-page":"48","article-title":"Enhancement of the immunogenicity of influenza a virus by the inhibition of immunosuppressive function of NS1 protein","volume":"5","author":"Vasilyev","year":"2018","journal-title":"Microbiol Independ Res J (MIR J)"},{"key":"10.1016\/j.vaccine.2025.127626_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040690","article-title":"Intranasal immunization with the influenza a virus encoding truncated NS1 protein protects mice from heterologous challenge by restraining the inflammatory response in the lungs","volume":"9","author":"Vasilyev","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2025.127626_bb0115","article-title":"Sequential immunization with live-attenuated chimeric hemagglutinin-based vaccines confers heterosubtypic immunity against influenza a viruses in a preclinical ferret model","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"issue":"Suppl. 7","key":"10.1016\/j.vaccine.2025.127626_bb0120","first-page":"33","article-title":"Vaccine-induced T cell protection from influenza viruses","volume":"25","author":"Valkenburg","year":"2019","journal-title":"Hong Kong Med J"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127626_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2025.127626_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-3083.2006.01862.x","article-title":"A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice","volume":"65","author":"Hauge","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0135","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127626_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67172-6","article-title":"T-cell responses following natural influenza infection or vaccination in solid organ transplant recipients","volume":"10","author":"L\u2019Huillier","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127626_bb0145","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0150","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1128\/JVI.00609-11","article-title":"A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains","volume":"85","author":"Hai","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0155","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1128\/JVI.01213-08","article-title":"Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach","volume":"82","author":"Hai","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1097349","article-title":"Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses","volume":"11","author":"Puente-Massaguer","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0165","first-page":"51112","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2025.127626_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/vaccines6030047","article-title":"A live-attenuated prime, inactivated boost vaccination strategy with chimeric hemagglutinin-based universal influenza virus vaccines provides protection in ferrets: a confirmatory study","volume":"6","author":"Nachbagauer","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127626_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02005","article-title":"Vaccination with viral vectors expressing chimeric hemagglutinin, NP and M1 antigens protects ferrets against influenza virus challenge","volume":"10","author":"McMahon","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41541-024-01014-8","article-title":"Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach","volume":"9","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127626_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105954","article-title":"Boosting the immune response in COVID-19 vaccines via an alum:CpG complex adjuvant","volume":"229","author":"Ji","year":"2024","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2025.127626_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj5305","article-title":"An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice","volume":"14","author":"Nanishi","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127626_bb0195","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1900022","article-title":"Chimeric hemagglutinin-based influenza virus vaccines induce protective stalk-specific humoral immunity and cellular responses in mice","volume":"3","author":"Choi","year":"2019","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.vaccine.2025.127626_bb0205","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.2004783117","article-title":"Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes","volume":"117","author":"Liao","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.127626_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.159.2.365","article-title":"Most influenza a virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants","volume":"159","author":"Kees","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.127626_bb0215","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/267354a0","article-title":"Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type a viruses","volume":"267","author":"Zweerink","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127626_bb0220","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza a virus nucleoprotein is a major target antigen for cross-reactive anti-influenza a virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.127626_bb0225","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.1007270107","article-title":"Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza a viruses","volume":"107","author":"Gras","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.127626_bb0230","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1128\/JVI.76.10.4886-4890.2002","article-title":"Protective cross-reactive cellular immunity to lethal a\/goose\/Guangdong\/1\/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon","volume":"76","author":"Seo","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0235","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1099\/vir.0.033076-0","article-title":"Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza a (H3N2) virus is mediated by virus-specific T-cells","volume":"92","author":"Hillaire","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127626_bb0245","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e19","article-title":"Influenza virus-derived CD8 T cell epitopes: implications for the development of universal influenza vaccines","volume":"24","author":"Kim","year":"2024","journal-title":"Immune Netw"},{"key":"10.1016\/j.vaccine.2025.127626_bb0250","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2025.127626_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2014.05.016","article-title":"T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine","volume":"27","author":"Li","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127626_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02312","article-title":"Cross-protective immune responses induced by sequential influenza virus infection and by sequential vaccination with inactivated influenza vaccines","volume":"9","author":"Dong","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127626_bb0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.12662","article-title":"CD4 t cells in protection from influenza virus: viral antigen specificity and functional potential","volume":"284","author":"Sant","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2025.127626_bb0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127626_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103131","article-title":"Synergistic effect of non-neutralizing antibodies and interferon-\u03b3 for cross-protection against influenza","volume":"24","author":"Shibuya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2025.127626_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2024.101409","article-title":"Journey of monocytes and macrophages upon influenza a virus infection","volume":"66","author":"Ruscitti","year":"2024","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0285","first-page":"8028725","article-title":"The role of innate leukocytes during influenza virus infection","volume":"1","author":"Lamichhane","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2025.127626_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa4352","article-title":"Neutrophil trails guide influenza-specific CD8+ T cells in the airways","volume":"349","author":"Lim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127626_bb0295","article-title":"Neutrophils and influenza: a thin line between helpful and harmful","volume":"9","author":"George","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127626_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/JLB.4RU0820-232R","article-title":"From virus to inflammation, how influenza promotes lung damage","volume":"110","author":"Klomp","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2012.05.005","article-title":"Immunopathology in influenza virus infection: uncoupling the friend from foe","volume":"144","author":"Damjanovic","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01646-22","article-title":"Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza a viruses","volume":"97","author":"Rijnink","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127626_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127626_bb0320","article-title":"Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate a(H1N1)pdm09 disease","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127626_bb0325","article-title":"Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protection","author":"Wittwer","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.vaccine.2025.127626_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009724","article-title":"A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells","volume":"17","author":"Ko","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127626_bb0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/imcb.12324","article-title":"Antibody-mediated complement activation in pathology and protection","volume":"98","author":"Goldberg","year":"2020","journal-title":"Immunol Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:36:25Z","timestamp":1779942985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":67,"alternative-id":["S0264410X25009235"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127626","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate and T-cellular immune responses to sequential vaccination with chimeric hemagglutinin split influenza virus vaccines in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127626"}}